MAM
ARMP icon

Madison Asset Management’s Armata Pharmaceuticals ARMP Stock Holding History

Madison Asset Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.6M Buy
+2,107,675
New +$17.7M 0.27% 94

Other funds holding ARMP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Madison Asset Management's ARMP Position: Q1 2026 in Review

Madison Asset Management opened a new position in Armata Pharmaceuticals (ARMP) in Q1 2026: 2,107,675 shares worth $21.6M. The stake represents 0.27% of the portfolio and ranks #94 among its holdings.

45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Madison Asset Management held 2,107,675 shares of Armata Pharmaceuticals worth $21.6M as of Q1 2026.
  • Armata Pharmaceuticals was a new Madison Asset Management position in Q1 2026.
  • Armata Pharmaceuticals made up 0.27% of Madison Asset Management's portfolio in Q1 2026, its #94 holding.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Madison Asset Management's 13F filing for Q1 2026, filed 7 May 2026.